A small case series conducted by researchers from the Celiac Center at Beth Israel Deaconess Medical Center highlighted the potential of an enteric-release, oral budesonide as a treatment for acute reactions to gluten exposure in patients with celiac disease.
Celiac Center physician, Ciaran Kelly, MD, and colleagues wrote that inadvertent exposure to gluten is still common even though patients specifically try to avoid it.
“Previous reports showed that budesonide may induce clinical and histologic response in refractory celiac disease,” they wrote. “Budesonide has been used

Source link